Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
van der Helm, Lieke H., Alhan, Canan, Wijermans, Pierre W., van Marwijk Kooy, Marinus, Schaafsma, Ron, Biemond, Bart J., Beeker, Aart, Hoogendoorn, Mels, van Rees, Bastiaan P., de Weerdt, Okke, Wegman, Jurgen, Libourel, Ward J., Luykx‐de Bakker, Sylvia A., Minnema, Monique C., Brouwer, Rolf E., Croon‐de Boer, Fransien, Eefting, Matthijs, Jie, Kon‐Siong G., van de Loosdrecht, Arjan A., Koedam, Jan, Veeger, Nic J. G. M, Vellenga, Edo, Huls, Gerwin
Published in British journal of haematology (01.12.2011)
Published in British journal of haematology (01.12.2011)
Get full text
Journal Article
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
Leeksma, Alexander C., Taylor, Justin, Wu, Bian, Gardner, Jeffrey R., He, Jie, Nahas, Michelle, Gonen, Mithat, Alemayehu, Wendimagegn G., te Raa, Doreen, Walther, Tatjana, Hüllein, Jennifer, Dietrich, Sascha, Claus, Rainer, de Boer, Fransien, de Heer, Koen, Dubois, Julie, Dampmann, Maria, Dürig, Jan, van Oers, Marinus H. J., Geisler, Christian H., Eldering, Eric, Levine, Ross L., Miller, Vincent, Mughal, Tariq, Lamanna, Nicole, Frattini, Mark G., Heaney, Mark L., Zelenetz, Andrew, Zenz, Thorsten, Abdel-Wahab, Omar, Kater, Arnon P.
Published in Leukemia (01.02.2019)
Published in Leukemia (01.02.2019)
Get full text
Journal Article
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
de Weerdt, Iris, Hofland, Tom, de Boer, Renate, Dobber, Johan A., Dubois, Julie, van Nieuwenhuize, Denise, Mobasher, Mehrdad, de Boer, Fransien, Hoogendoorn, Mels, Velders, Gerjo A., van der Klift, Marjolein, Remmerswaal, Ester B.M., Bemelman, Frederike J., Niemann, Carsten U., Kersting, Sabina, Levin, Mark-David, Eldering, Eric, Tonino, Sanne H., Kater, Arnon P.
Published in Blood advances (10.09.2019)
Published in Blood advances (10.09.2019)
Get full text
Journal Article
P1523: IMMUNOGENICITY OF THE 13‐VALENT PNEUMOCOCCAL CONJUGATED VACCINE FOLLOWED BY THE 23‐VALENT POLYSACCHARIDE VACCINE IN CHRONIC LYMPHOCYTIC LEUKEMIA
Haggenburg, Sabine, Garrido, Hannah Garcia, Kant, Iris, Straaten, Hanneke, Boer, Fransien De, Kersting, Sabina, Issa, Djamila, Raa, Doreen Te, Visser, Hein, Kater, Arnon, Goorhuis, Abraham, Heer, Koen De
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia
Haggenburg, Sabine, Garcia Garrido, Hannah M, Kant, Iris M J, Van der Straaten, Hanneke M, De Boer, Fransien, Kersting, Sabina, Issa, Djamila, Te Raa, Doreen, Visser, Hein P J, Kater, Arnon P, Goorhuis, Abraham, De Heer, Koen
Published in Vaccines (Basel) (01.07.2023)
Published in Vaccines (Basel) (01.07.2023)
Get full text
Journal Article
P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT‐ACALL TRIAL
Niemann, Carsten, Levin, Mark‐David, Österborg, Anders, Lundin, Jeanette, Kättström, Magdalena, Vollerup, Jeanette, Da Cunha‐Bang, Caspar, Foraux, Michael, Brieghel, Christian, Boer, Fransien, Enggaard, Lisbeth, Bjorn Poulsen, Christian, Reekie, Joanne, Agius, Rudi
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB‐VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL
Kersting, Sabina, Levin, Mark‐David, Dubois, Julie, Norden, Yvette, Dobber, Johan, Jauw, Yvonne, Kevie‐Kersemaekers, Anne‐Marie, Mellink, Clemens, Da Cunha‐Bang, Caspar, Van Desr Burg, Leonie, Te Raa, Doreen, Boer, Fransien, Droogendijk, Jolanda, Idink, Cecile, De Heer, Koen, Nijziel, Marten, Tick, Lidwine, Ludwig, Inge, Silbermann, Mathijs, Beeker, Aart, Bellido, Mar, Evers, Ludo, Zwezerijnen, Gerben, Zijlstra, Josée, Kap, Marcel, Niemann, Carsten, Kater, Arnon
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P877: IXAZOMIB DARATUMUMAB AND LOW‐DOSE DEXAMETHASONE IN INTERMEDIATE‐FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
Groen, Kaz, Stege, Claudia, Nasserinejad, Kazem, Heer, Koen, Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka‐Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie‐Christiane, Donk, Niels W.C.J., Timmers, Gert‐Jan, Boer, Fransien, Tick, Lidwine W., Spek, Ellen, Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., Levin, Mark‐David, Ypma, Paula F., Zweegman, Sonja
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia
Tonino, Sanne H., Mulkens, Chantal E., van Laar, Jacoline, Derks, Ingrid A. M., Suo, Guangli, Croon-de Boer, Fransien, van Oers, Marinus H. J., Eldering, Eric, Wang, Jean Y., Kater, Arnon P.
Published in Leukemia & lymphoma (03.08.2015)
Published in Leukemia & lymphoma (03.08.2015)
Get full text
Journal Article
Immunogenicity of the Currently Recommended Pneumococcal Vaccination Schedule in Patients with Chronic Lymphocytic Leukaemia
Haggenburg, Sabine, Garcia Garrido, Hannah, Kant, Iris, De Boer, Fransien, Kersting, Sabina, Raa, Doreen te, Issa, Djamila E., Otten, Henny G., Visser, Hein P.J., Kater, Arnon P., Goorhuis, Abraham, de Heer, Koen
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
Broome, Catherine M, McDonald, Vickie, Miyakawa, Yoshitaka, Carpenedo, Monica, Kuter, David J, Al-Samkari, Hanny, Bussel, James B, Godar, Marie, Ayguasanosa, Jaume, De Beuf, Kristof, Rodeghiero, Francesco, Michel, Marc, Newland, Adrian, Fillitz, Michael, Knoebl, Paul, Meers, Stef, Amine, Ismail Mohamad, Gumulec, Jaromir, Hlusi, Antonin, Mayer, Jiri, Quittet, Philippe, Viallard, Jean-Francois, Betaneli, Magdana, Datikashvili-David, Irine, Iosava, Genadi, Makhaldiani, Levan, Rejto, Laszlo, Sharashenidze, Nino, Groepper, Stefanie, Röth, Alexander, Hamed, Aryan, Illes, Arpad, Artoni, Andrea, Bocchia, Monica, Gamberi, Barbara, Borchiellini, Alessandra, Oliva, Esther Natalie, Patriarca, Andrea, Tomassetti, Simona, Ando, Kiyoshi, Handa, Hiroshi, Katsutani, Shinya, Nishiwaki, Kaichi, Ito, Shoko, Ito, Tomoki, de Boer, Fransien, Jansen, A.J. Gerard, Ciepluch, Hanna, Fornagiel, Szymon, Grosicki, Sebastian, Soroka-Wojtaszko, Maria, Trelinski, Jacek, Bakirov, Bulat, Borisenkova, Elena, Volodicheva, Elena, Shatokhin, Yuri, Proydakov, Andrey, Alonso, Maria Aranzazu, Mingot-Castellano, María Eva, Sanchez-Gonzalez, Blanca, Valcarcel Ferreiras, David, Ayli, Meltem, Hacibekiroglu, Tuba, Demir, Ahmet Muzaffer, Nalçaci, Meliha, Sonmez, Mehmet, Tombak, Anil, Toprak, Selami Kocak, Turgut, Burhan, Vural, Filiz, Yagci, Munci, Altuntas, Fevzi, Turgut, Mehmet, Kaya, Emin, Romanyuk, Nataliya, Kazmi, Syed Rashid Saeed, Broome, Catherine, Cataland, Spero, Doshi, Ketan, Lentz, Steven R., Boxer, Michael, Rosenberg, Richard
Published in The Lancet (British edition) (04.11.2023)
Published in The Lancet (British edition) (04.11.2023)
Get full text
Journal Article
Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study
Ruchlemer, Rosa, Ben‐Ami, Ronen, Bar‐Meir, Maskit, Brown, Jennifer R., Malphettes, Marion, Mous, Rogier, Tonino, Sanne H., Soussain, Carole, Barzic, Noelie, Messina, Julia A., Jain, Preetesh, Cohen, Regev, Hill, Brian, Mulligan, Stephen P., Nijland, Marcel, Herishanu, Yair, Benjamini, Ohad, Tadmor, Tamar, Okamoto, Koh, Arthurs, Benjamin, Gottesman, Batsheva, Kater, Arnon P., Talha, Munir, Eichhorst, Barbara, Korem, Maya, Bogot, Naama, De Boer, Fransien, Rowe, Jacob M., Lachish, Tamar
Published in Mycoses (01.12.2019)
Published in Mycoses (01.12.2019)
Get full text
Journal Article
Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the Phase 2 HOVON 158/Next STEP Trial
Levin, Mark-David, Kersting, Sabina, Dubois, Julie M.N., Norden, Yvette, Dobber, Johan A, Jauw, Yvonne W.S., Kevie-Kersemaekers, Anne-Marie van der, Mellink, Clemens, Heer, Koen de, Burg, Leonie van der, Raa, Doreen Te, Boer, Fransien de, Droogendijk, Jolanda, Idink, Cecile, Nijziel, Marten R., Tick, Lidwine W., Ludwig, Inge, Silbermann, Matthijs, Beeker, Aart, Bellido, Mar, Evers, Ludo M., Zwezerijnen, Gerben JC, Niemann, Carsten U, Kater, Arnon P.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL
van der Straten, Lina, Stege, Claudia A. M., Kersting, Sabina, Nasserinejad, Kazem, Dubois, Julie, Dobber, Johan A., Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie F., Evers, Ludo M., de Boer, Fransien, Koene, Harry R., Schreurs, John, van der Klift, Marjolein, Velders, Gerjo A., van der Spek, Ellen, van der Straaten, Hanneke M., Hoogendoorn, Mels, van Gelder, Michel, Posthuma, Eduardus F. M., Visser, Hein P. J., Houtenbos, Ilse, Idink, Cecile A. M., Issa, Djamila E., Dompeling, Ellen C., van Zaanen, Henk C. T., Veelken, J. Hendrik, Levenga, Henriette, Tick, Lidwine W., Terpstra, Wim E., Tonino, Sanne H., Westerweel, Peter E., Langerak, Anton W., Kater, Arnon P., Levin, Mark-David, Beckers, M. M. J., Bekker, A., Bellido, M., de Boer, F., Broers, R., Chamuleau, M., Croockewit, A. J., Dompeling, E. C., Eefting, M., van Gelder, M., Hoogendoorn, M., Houtenbos, I., Doorduijn, J. K., Droogendijk, J., van der Griend, R., de Heer, K., Henkens, C. M. A., Idink, C. A. M., Issa, D. E., van Kampen, R., Kater, A. P., Kersting, S., van der Klift, M., Laterveer, L., Levenga, H., Levin, M-D., Mous, R., Nijland, M., Nijziel, M., van Norden, Y., Posthuma, E. F. M., te Raa, G. D., Raymakers, R. A. P., Regelink, J. C., Sandberg, Y., Schaafsma, M. R., Silbermann, M. H., van der Spek, A. C., van der Straaten, H. M., Tanis, B., Terpstra, W. E., Tick, L. W., Tonino, S. H., Veelken, J. H., Velders, G. A., Vlasveld, L., Visser, H. P. J., Vos, J. M. I., Wittebol, S., van Zaanen, H. C. T.
Published in Blood (28.09.2023)
Published in Blood (28.09.2023)
Get full text
Journal Article
Ixazomib, Daratumumab and Low Dose Dexamethasone in Intermediate-Fit Patients with Newly Diagnosed Multiple Myeloma (NDMM); Results of Induction Treatment of the Phase II HOVON 143 Study
Groen, Kaz, Stege, Claudia A.M., Nasserinejad, Kazem, de Heer, Koen, Van Kampen, Roel J.W., Leijs, Maria B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka Lung, Ludwig, Inge, Issa, Djamila, Velders, Gerjo A., Vekemans, Marie-Christiane, van de Donk, Niels W.C.J., Timmers, Gert-Jan, Sonneveld, Pieter, Seefat, Maarten R., Croon-de Boer, Fransien, Tick, Lidwine W., van der Spek, Ellen, De Waal, Esther G.M., Sohne, Maaike, Ypma, Paula F, Nijhof, Inger S., Klein, Saskia K., Levin, Mark-David, Zweegman, Sonja
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry
Ekels, Afke, van de Poll-Franse, Lonneke V, Issa, Djamila E, Hoogendoorn, Mels, Nijziel, Marten R, Koster, Adrianus, de Jong, Cornelis N, Achouiti, Ahmed, Thielen, Noortje, Tick, Lidwine W, Te Boome, Liane C J, Bohmer, Lara H, Tiren-Verbeet, Nicolette L, Veldhuis, Gerrit J, de Boer, Fransien, van der Klift, Marjolein, Posthuma, Eduardus F M, Oerlemans, Simone
Published in Annals of hematology (16.09.2024)
Published in Annals of hematology (16.09.2024)
Get full text
Journal Article
First Evidence of Restoration of T and NK Cell Compartment after Venetoclax Treatment
de Weerdt, Iris, Hofland, Tom, Dobber, Johan, Dubois, Julie, Eldering, Eric, Mobasher, Mehrdad, Croon-de Boer, Fransien, Hoogendoorn, Mels, Velders, Gerjo A., van der Klift, Marjolein, Levin, Mark-David, Kersting, Sabina, Tonino, Sanne, Kater, Arnon P.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study
Saberi Hosnijeh, Fatemeh, van der Straten, Lina, Kater, Arnon P., van Oers, Marinus H.J., Posthuma, Ward F.M., Chamuleau, Martine E.D., Bellido, Mar, Doorduijn, Jeanette K., van Gelder, Michel, Hoogendoorn, Mels, de Boer, Fransien, te Raa, G. Doreen, Kerst, J. Martijn, Marijt, Erik W.A., Raymakers, Reinier A.P., Koene, Harry R., Schaafsma, Martijn R., Dobber, Johan A., Tonino, Sanne H., Kersting, Sabina S., Langerak, Anton W., Levin, Mark-David
Published in Experimental hematology (01.09.2020)
Published in Experimental hematology (01.09.2020)
Get full text
Journal Article
Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial
Kater, Arnon P., Van Oers, Marinus H.J. H.J., Norden, Yvette, Liu, Roberto D., Schipperus, Martin R., Chamuleau, Martine, Nijland, Marcel, Doorduijn, Jeanette K., van Gelder, Michel, Hoogendoorn, Mels, Croon-de Boer, Fransien, Wittebol, Shulamit, Kerst, Martijn, Marijt, Willem, Posthuma, Ward, Raymakers, Reinier, Schaafsma, Ron, Dobber, Johan, Kersting, Sabina, Levin, Mark-David
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial
Groen, Kaz, Stege, Claudia A.M., Nasserinejad, Kazem, de Heer, Koen, van Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka-Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie-Christiane, Timmers, Gert-Jan, de Boer, Fransien, Tick, Lidwine W., Verbrugge, Annelies, Buitenhuis, Danny, Cunha, Sonia M., van der Spek, Ellen, de Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., van de Donk, Niels W.C.J., Levin, Mark-David, Ypma, Paula F., Zweegman, Sonja
Published in EClinicalMedicine (01.09.2023)
Published in EClinicalMedicine (01.09.2023)
Get full text
Journal Article